In this Exclusive Interview, Dr. Espeland discusses the LOOK AHEAD study and its findings, including the impact of lifestyle interventions on healthcare costs, and why exercise and weight loss can reduce cognitive decline, but also increase risk of hypoglycemia.

Dr. Mark Espeland discusses the background of the LOOK AHEAD study, which examines the effects of lifestyle interventions on adults with diabetes.

Dr. Mark Espeland talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the LOOK AHEAD study's major findings, including the effectiveness of lifestyle interventions in reducing healthcare costs.

Dr. Mark Espeland talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the reasons why exercise and weight loss can improve cognitive function.

Dr. Mark Espeland talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the ten-year time period of the LOOK AHEAD study, and what it revealed about the benefit of long-term lifestyle interventions on cognitive health. Dr. Mark Espeland, PhD is the founding …

Many times we hear our patients complain that they are limited because of their diabetes, and they then start to regress, blaming the disease for everything. Would that be worse if you were a top athlete just coming into your prime? And what if your medical team told you that the sport …

In his fifth year with Team Novo Nordisk, Stephen Clancy is slated to race his second consecutive Tour of Utah. At last year’s race, Stephen said it was an unforgettable experience racing at arguably the toughest race in the United States.

Dr. Davidson discusses new diabetes drugs and their impact on patient health, including DKA; new combination drugs; and the expensive side effects of sulfonylureas.

In this Exclusive Interview, Dr. Davidson discusses his thoughts on new drugs and their impact on patient health, such as DKA.

In this week's Homerun Slides, the phenotypic presentation of the beta-cell.